134 related articles for article (PubMed ID: 18079582)
1. Transient asymptomatic bradycardia in patients on infusional 5-fluorouracil.
Talapatra K; Rajesh I; Rajesh B; Selvamani B; Subhashini J
J Cancer Res Ther; 2007; 3(3):169-71. PubMed ID: 18079582
[TBL] [Abstract][Full Text] [Related]
2. Symptomatic 5-fluorouracil-induced sinus bradycardia.
Lee AD; McKay MJ
Intern Med J; 2011 Jul; 41(7):566-70. PubMed ID: 21762335
[TBL] [Abstract][Full Text] [Related]
3. Capecitabine induced cardiotoxicity: a case report and review of literature.
Tunio MA; Hashmi A; Shoaib M
Pak J Pharm Sci; 2012 Jan; 25(1):277-81. PubMed ID: 22186341
[TBL] [Abstract][Full Text] [Related]
4. A retrospective study of cardiotoxicities induced by 5-fluouracil (5-FU) and 5-FU based chemotherapy regimens in Pakistani adult cancer patients at Shaukat Khanum Memorial Cancer Hospital & Research Center.
Khan MA; Masood N; Husain N; Ahmad B; Aziz T; Naeem A
J Pak Med Assoc; 2012 May; 62(5):430-4. PubMed ID: 22755303
[TBL] [Abstract][Full Text] [Related]
5. Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy -- a survey of 427 patients.
Tsavaris N; Kosmas C; Vadiaka M; Efremidis M; Zinelis A; Beldecos D; Sakelariou D; Koufos C; Stamatelos G
Med Sci Monit; 2002 Jun; 8(6):PI51-7. PubMed ID: 12070449
[TBL] [Abstract][Full Text] [Related]
6. [Bradyarrhythmia after chemotherapy with 5-fluorouracil].
Schneider M; Schneider G
Dtsch Med Wochenschr; 2002 May; 127(22):1192. PubMed ID: 12035115
[No Abstract] [Full Text] [Related]
7. Symptomatic cardiotoxicity associated with 5-fluorouracil.
Meyer CC; Calis KA; Burke LB; Walawander CA; Grasela TH
Pharmacotherapy; 1997; 17(4):729-36. PubMed ID: 9250550
[TBL] [Abstract][Full Text] [Related]
8. A new perspective on cardiotoxicity of 5-fluorouracil. A novel research tool 'cardiac ultrasonic integrated backscatter analysis' indicates transient, subclinical myocardial dysfunction due to high-dose leucovorin and infusional 5-fluorouracil regimen.
Barutca S; Ceyhan C; Meydan N; Ozturk B; Tekten T; Onbasili A; Kadikoylu G; Bolaman Z
Chemotherapy; 2004 Jun; 50(3):113-8. PubMed ID: 15272225
[TBL] [Abstract][Full Text] [Related]
9. Supraventricular arrhythmia: a complication of 5-fluorouracil therapy.
Aziz SA; Tramboo NA; Mohi-ud-Din K; Iqbal K; Jalal S; Ahmad M
Clin Oncol (R Coll Radiol); 1998; 10(6):377-8. PubMed ID: 9890539
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the comparative toxicity of 5-FU bolus versus 5-FU continuous infusion circadian chemotherapy with concurrent radiation therapy in locally advanced rectal cancer.
Thrall MM; Wood P; King V; Rivera W; Hrushesky W
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):873-81. PubMed ID: 10705008
[TBL] [Abstract][Full Text] [Related]
11. High incidence of angina pectoris in patients treated with 5-fluorouracil. A planned surveillance study with 102 patients.
Wacker A; Lersch C; Scherpinski U; Reindl L; Seyfarth M
Oncology; 2003; 65(2):108-12. PubMed ID: 12931015
[TBL] [Abstract][Full Text] [Related]
12. Bolus 5-Fluorouracil as an alternative modality to infusion 5-Fluorouracil in a patient with rectal cancer and capecitabine-induced cardiotoxicity.
Shaib W; Lee V; Saif MW
In Vivo; 2009; 23(5):821-6. PubMed ID: 19779118
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic options in patients with 5-fluorouracil-associated cardiotoxicity.
Cianci G; Morelli MF; Cannita K; Morese R; Ricevuto E; Di Rocco ZC; Porzio G; Lanfiuti Baldi P; Ficorella C
Br J Cancer; 2003 May; 88(10):1507-9. PubMed ID: 12771913
[TBL] [Abstract][Full Text] [Related]
14. Bolus 5-fluorouracil as an alternative in patients with cardiotoxicity associated with infusion 5-fluorouracil and capecitabine: a case series.
Saif MW; Garcon MC; Rodriguez G; Rodriguez T
In Vivo; 2013; 27(4):531-4. PubMed ID: 23812226
[TBL] [Abstract][Full Text] [Related]
15. [Cardiotoxicity of 5-fluorouracil].
Pan L; Yang X; Song H
Zhonghua Fu Chan Ke Za Zhi; 1996 Feb; 31(2):86-9. PubMed ID: 8758800
[TBL] [Abstract][Full Text] [Related]
16. [5-fluorouracil: cause of a fatal myocardial infarction in combined radiochemotherapy?].
Maurer U; Härle M; Jungius KP
Strahlenther Onkol; 1996 May; 172(5):257-9. PubMed ID: 8633257
[TBL] [Abstract][Full Text] [Related]
17. Toxicity of 5-fluorouracil.
Macdonald JS
Oncology (Williston Park); 1999 Jul; 13(7 Suppl 3):33-4. PubMed ID: 10442356
[TBL] [Abstract][Full Text] [Related]
18. Severe cardiotoxicity during 5-fluorouracil chemotherapy: a case and literature report.
Kuropkat C; Griem K; Clark J; Rodriguez ER; Hutchinson J; Taylor SG
Am J Clin Oncol; 1999 Oct; 22(5):466-70. PubMed ID: 10521060
[TBL] [Abstract][Full Text] [Related]
19. High-dose cytosine arabinoside-induced symptomatic bradycardia.
Wayangankar SA; Patel BC; Parekh HD; Holter JL; Lazzara R
J Cardiovasc Med (Hagerstown); 2015 Jan; 16 Suppl 1():S38-41. PubMed ID: 21178637
[TBL] [Abstract][Full Text] [Related]
20. A Case of 5-Fluorouracil-Induced Cardiac Arrest.
Ray JC; Cho P; Dragon M; Graham CG
J Emerg Med; 2016 Jan; 50(1):e1-6. PubMed ID: 26482827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
